Piper Sandler has reaffirmed its confidence in cybersecurity firm CrowdStrike Holdings (NASDAQ: NASDAQ:CRWD), maintaining an Overweight rating and a price target of $290.00 on the company's stock.

Piper Sandler analyst Adam Maeder maintained a Hold rating on Axonics Modulation Technologies (AXNX – Research Report) today and set a price target of $71.00. The company’s shares closed ...

JMP Securities analyst Devin Ryan maintained a Hold rating on Piper Sandler (PIPR – Research Report) today. The company’s shares closed yesterday at $271.44. According to TipRanks, Ryan is a ...

Piper Sandler has reaffirmed its confidence in HubSpot Inc (NYSE: NYSE:HUBS), maintaining an Overweight rating and a $570.00 price target for the company's stock. The firm's endorsement comes as ...

Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) turned lower on Wednesday after Piper Sandler downgraded the company, citing a more muted growth trajectory for Qelbree, its treatment for ...

Piper Sandler has maintained a Neutral rating and an $8.00 price target for Hain Celestial (NASDAQ: NASDAQ:HAIN), following the divestiture of its ParmCrisp business. The firm has adjusted its ...

MINNEAPOLIS, September 16, 2024--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Steve Tipler as a managing director in the ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Insulet (PODD – Research Report) today and set a price target of $285.00. The company’s shares closed yesterday at $233.89.

Shares of e.l.f. Beauty (ELF) are falling after Piper Sandler slashed the beauty company's price target to $162 per share from $260 despite reiterating its Overweight rating. Market Domination ...

Investing.com -- Piper Sandler initiated coverage on Abbott Laboratories (NYSE:ABT) with an "overweight" rating and a price target of $131 per share. Piper Sandler emphasizes Abbott’s ...

Fintel reports that on September 11, 2024, Piper Sandler downgraded their outlook for Supernus Pharmaceuticals (LSE:0LB2) from Overweight to Neutral. There are 555 funds or institutions reporting ...

Piper Sandler has sustained its Overweight rating and $26.00 price target for Zura Bio Ltd. (NASDAQ: ZURA), following a successful investor event in New York City. The firm highlighted the ...